glp 1 agonist weight loss mechanism Frontiers Frontiers | Mechanisms of action

Leveraging Catalent's advanced infrastructure in fill-finish manufacturing, this acquisition aims to meet the surging demand for diabetes and weight management treatments

Incretins are a type of hormone that stimulate a decrease in blood glucose levels, such as GLP-1 that binds to and activates the GLP-1 receptor

21-24 The Free Fatty Acid Receptor 1 (FFAR1) in the gut, activated by the intake of EPA and DHA, facilitates the glucose-stimulated insulin secretion from pancreatic -cells, while G-Protein Coupled Receptor 120 (GPR120) that regulates the secretion GLP-1 can also be upregulated by EPA and DHA intake

The oral Wegovy pill will be available via prescription.

Conflicting resultsneed for more transparent and reproducible research

Many of the cardiovascular and metabolic trials informing the discussion were not designed to evaluate ophthalmic outcomes. The authors called for prospective ophthalmology-specific studies incorporating imaging biomarkers, visual outcomes and disease-specific monitoring, noting that parsing the protective benefits or adverse effects of this rapidly growing medication class will be essential to refining disease management and improve patient outcomes. As GLP-1 therapies become increasingly common among patients with diabetes, obesity and vascular comorbiditiesprecisely the populations populating ophthalmic clinicsthe field may not have the luxury of waiting for cleaner data